Andreea M. Bujor MD, PhD
Associate Professor, Rheumatology
Associate Program Director, Rheumatology Fellowship Program
72 East Concord Street | (617) 638-4312andreea@bu.edu

Sections
Rheumatology
Centers
Arthritis & Autoimmune Diseases Research Center
Evans Center for Interdisciplinary Biomedical Research
Biography
I am an Associate Professor of Medicine in the Section of Rheumatology at Boston University School of Medicine, specializing in scleroderma translational research and in the care of patients with scleroderma.
My research focuses on the interplay between myeloid cells and fibroblasts in scleroderma-associated cardiac fibrosis. Our project investigating the role of the transcription factor Fli1 in myeloid cells has received funding from the NIH, American Heart Association, and Rheumatology Research Foundation. Additionally, we are exploring a method called spatial frequency domain imaging as a non-invasive tool for assessing skin fibrosis in scleroderma patients, a project supported by the Scleroderma Clinical Trials Consortium and National Scleroderma Foundation.
Beyond research, I am deeply committed to mentoring and education. As the Associate Program Director for the Rheumatology Fellowship, I have mentored trainees at all levels, and received an Outstanding Mentor Award from UROP. I regularly lecture on scleroderma and rheumatology and lead board review sessions for fellows. In recognition of my contributions to clinical care and research, I was honored as one of Boston’s Top Doctors in 2024 and 2025.
Education
Medicine, MD, Iuliu Hațieganu University of Medicine and Pharmacy
Medicine, PhD, Iuliu Hațieganu University of Medicine and Pharmacy
Molecular Biology, MS, Iuliu Hațieganu University of Medicine and Pharmacy
Publications
Darbousset R, Senkpeil L, Kuehn J, Balu S, Miglani D, Dillon E, Fromson C, Elahee M, Jarrot PA, Montesi SB, Rao DA, Ware J, Wagner DD, Bujor AM, Gutierrez-Arcelus M, Nigrovic PA. A GPVI-platelet-neutrophil-NET axis drives systemic sclerosis. bioRxiv. 2025 Jan 24. PMID: 39896646.
Published on 12/9/2024Lui JK, Cozzolino M, Winburn M, Trojanowski MA, Soylemez Wiener R, LaValley MP, Bujor AM, Gopal DM, Klings ES. Clustering regional patterns of left ventricular longitudinal strain in systemic sclerosis-related pulmonary hypertension. Int J Cardiol. 2025 Feb 15; 421:132891. PMID: 39662748.
Published on 8/7/2024Yamashita T, Kaplan U, Chakraborty A, Marden G, Gritli S, Roh D, Bujor A, Trojanowski M, Ligresti G, Browning JL, Trojanowska M. ERG Regulates Lymphatic Vessel Specification Genes and Its Deficiency Impairs Wound Healing-Associated Lymphangiogenesis. Arthritis Rheumatol. 2024 Nov; 76(11):1645-1657. PMID: 38965683.
Published on 6/27/2024Raslan AA, Pham TX, Lee J, Kontodimas K, Tilston-Lunel A, Schmottlach J, Hong J, Dinc T, Bujor AM, Caporarello N, Thiriot A, von Andrian UH, Huang SK, Nicosia RF, Trojanowska M, Varelas X, Ligresti G. Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis. Nat Commun. 2024 Jun 27; 15(1):5449. PMID: 38937456.
Published on 6/1/2024Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2024 Jun; 38(3):657. PMID: 36662449.
Published on 12/19/2023Lui JK, Cozzolino M, Winburn M, Trojanowski MA, Wiener RS, LaValley MP, Bujor AM, Gopal DM, Klings ES. Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension. Chest. 2024 Jun; 165(6):1505-1517. PMID: 38128607.
Published on 11/13/2023Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension. Lung. 2023 Dec; 201(6):565-569. PMID: 37957388.
Published on 6/17/2023Vakhshoorzadeh J, Lui JK, Sangani RA, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension. Respir Med. 2023 Sep; 216:107333. PMID: 37336329.
Published on 5/25/2023Pilvar A, Mehendale AM, Karrobi K, El-Adili F, Bujor A, Roblyer D. Spatial frequency domain imaging for the assessment of scleroderma skin involvement. Biomed Opt Express. 2023 Jun 01; 14(6):2955-2968. PMID: 37342706.
Published on 1/23/2023El-Adili F, Lui JK, Najem M, Farina G, Trojanowska M, Sam F, Bujor AM. Correction: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications. Arthritis Res Ther. 2023 Jan 23; 25(1):11. PMID: 36691037.